公开(公告)号：US20190144841A1

公开(公告)日：2019-05-16

申请号：US16200269

申请日：2018-11-26

Applicant: ACADEMIA SINICA

Inventor： Jui-Jen CHANG ,  Caroline THIA ,  Hao-Yeh LIN ,  Yu-Ju LIN ,  Chieh-Chen HUANG ,  Wen-Hsiung LI

IPC: C12N9/14 ,  C12P23/00 ,  C12N15/81

Abstract: Disclosed herein are recombinant polynucleotide sequences, vectors, host cells and methods for producing astaxanthin. The recombinant polynucleotide sequence is designed to provide a higher level of astaxanthin precursors via a shorter metabolic pathway, and thereby attains higher level of end products (e.g., astaxanthin) with desired stereoisomeric form and/or esterified form.

公开(公告)号：US20210363196A1

公开(公告)日：2021-11-25

申请号：US17327514

申请日：2021-05-21

Applicant: ACADEMIA SINICA

Inventor： Wen-Hsiung LI ,  Anandharaj MARIMUTHU ,  Jui-Jen CHANG ,  Yu-Ju LIN ,  Rizwana Parveen Rani MOHAMED GOBIL ,  Chieh-Chen HUANG

IPC: C07K14/195 ,  C12P7/06 ,  C12P19/02 ,  C12P19/14 ,  C12N9/42 ,  C12N9/02

Abstract: The present disclosure relates to a recombinant protein comprising a plurality of type II cohesin repeats. The present disclosure provides a recombinant cellulosome complex comprising: the recombinant protein comprising a plurality of type II cohesin repeats; a recombinant cellulosome complex integrating protein A comprising a plurality of type I cohesin repeats, a plurality of cellulose-binding modules and a type II dockerin; and a plurality of recombinant enzymes each comprising a type I dockerin. A cell, a method for digesting a cellulose and a method for producing ethanol are also provided.

公开(公告)号：US20170137792A1

公开(公告)日：2017-05-18

申请号：US15353372

申请日：2016-11-16

Applicant: ACADEMIA SINICA

Inventor： Jui-Jen CHANG ,  Caroline THIA ,  Hao-Yeh LIN ,  Yu-Ju LIN ,  Chieh-Chen HUANG ,  Wen-Hsiung LI

IPC: C12N9/14 ,  C12N15/81 ,  C12P23/00

Abstract: Disclosed herein are recombinant polynucleotide sequences, vectors, host cells and methods for producing astaxanthin. The recombinant polynucleotide sequence is designed to provide a higher level of astaxanthin precursors via a shorter metabolic pathway, and thereby attains higher level of end products (e.g., astaxanthin) with desired stereoisomeric form and/or esterified form.